Work

Complementary combinations: what treatments will become key to the battle against acute myelogenous leukemia?

Year: 2012

Type: article

Source: Expert Review of Hematology

DOI: 10.1586/ehm.12.43

Authors: Prithviraj Bose, Steven Grant

Institutions: Virginia Commonwealth University, VCU Massey Comprehensive Cancer Center, Virginia Commonwealth University Medical Center

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Cancer Institute

Awards: G131572022, G1949115589, G2721733520, G299731492, SPORE in Lymphoma, G3148123924, G4639764867, M. D. Anderson Cancer Center SPORE in Multiple Myeloma, NF-kappaB Inhibitors and Differentiation-Inducers in Leukemia, Proteasome/HDAC Inhibition in Leukemia/MDS; Phase I Trial and Correlative Studies, G8382235333, Phase I Trial of Bortezomib and Romidepsin in CLL and Small Cell Lymphoma

OpenAlex ID: W2017001976

FWCI: 0.192

Cites: 25

Cited by: 4

Related to: 10